Bronswijk M, Moens A, Lenfant M, Tops S, et al. Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center. Inflamm Bowel Dis 2020;26:628-634.
PMID: 31400283